SynergyMed

SynergyMed

A medical device startup company focused on cancer tumor treatment for human and veterinary applications.

Founded 2019 17 employees Seed Health Care, Medical Devices

SynergyMed is a medical device startup company with a focus on cancer tumor treatment for both human and veterinary applications. The company, founded in 2019, operates as a C-Corp and has developed a proven technology in the field. SynergyMed's core objective is the development of cancer treatment products based on an innovative noninvasive ablation technology, primarily targeting early-stage breast, head & neck, skin, and lung cancers, as well as offering pain relief in palliative care treatments. The technology utilizes noninvasive electromagnetic applicators along with FDA/CE approved nanoparticles to achieve local tumor ablation without causing harm to surrounding healthy tissues. The company has conducted successful tests on mice and is currently conducting trials on dogs for the veterinary market, with plans for first-in-human studies in the pipeline. In its current stage, SynergyMed is actively seeking VC funding and aiming to establish strategic partnerships with major medical device corporations and hospital consortiums. Additionally, the company is accepting pre-orders for its devices in R&D and veterinary applications. For private investors, there is an opportunity to participate in SynergyMed's equity-based crowdfunding campaign via https://wefunder.com/synergymed/. With its technological promise and the potential to revolutionize cancer treatment, SynergyMed presents a compelling opportunity for investors to support innovative solutions in the healthcare and medical devices industries. The recent Seed Round investment on 26 May 2022 signifies the company's growth trajectory and its appeal to potential investors seeking to engage with pioneering advancements in cancer treatment technologies.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	Undisclosed	-		26 May 2022
Pre Seed Round	Undisclosed	-		01 Jun 2019

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

Undisclosed

26 May 2022

Pre Seed Round

Undisclosed

01 Jun 2019

FAQ About SynergyMed

A medical device startup company focused on cancer tumor treatment for human and veterinary applications.

SynergyMed was founded in 2019.

SynergyMed operates in Health Care and Medical Devices.

SynergyMed has approximately 17 employees.

SynergyMed has completed 2 funding rounds. The latest funding stage is Seed.

Top alternatives and competitors to SynergyMed include Novian Health, RTsafe, Aethlon Medical, Inc., Taurus Vascular, Free Flow Medical, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

SynergyMed and Novian Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About SynergyMed

Funding Rounds & Investors (2)

SynergyMed Alternatives & Competitors

FAQ About SynergyMed